SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-21-000007
Filing Date
2021-05-12
Accepted
2021-05-12 08:47:36
Documents
86
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20210331.htm   iXBRL 10-Q 1470594
2 EX-10.1 exhibit101-q0121.htm EX-10.1 54299
3 EX-10.2 exhibit102-q0121.htm EX-10.2 66955
4 EX-31.1 exhibit311-q0121.htm EX-31.1 6551
5 EX-31.2 exhibit312-q0121.htm EX-31.2 6538
6 EX-32.1 exhibit321-q0121.htm EX-32.1 3363
  Complete submission text file 0001601830-21-000007.txt   6791995

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20210331.xsd EX-101.SCH 49991
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20210331_cal.xml EX-101.CAL 71941
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20210331_def.xml EX-101.DEF 264783
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20210331_lab.xml EX-101.LAB 598940
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20210331_pre.xml EX-101.PRE 416717
12 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20210331_htm.xml XML 931430
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 21913602
SIC: 2836 Biological Products, (No Diagnostic Substances)